Finance Home - My Yahoo - Yahoo! - Help

Thursday, November 26, 2009, 5:27PM ET - U.S. Markets Closed for Thanksgiving Day. Dow  0.29% Nasdaq  0.32%

Theravance Inc. (THRX)

On Nov 25: 13.13   0.27 (2.01%)

MORE ON THRX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Today, Thu, Nov 26, 2009 • Theravance, Inc.: Wait to Buy on Dip at Seeking Alpha (Thu 6:19am) Fri, Nov 13, 2009 • Unique Strategy Generates Big Returns for Baupost Indie Research (Fri, Nov 13) Tue, Nov 10, 2009 • THERAVANCE INC Financials EDGAR Online Financials (Tue, Nov 10) Thu, Nov 5, 2009 • Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States Marketwire (Thu, Nov 5) Wed, Nov 4, 2009 • THERAVANCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Nov 4) Tue, Nov 3, 2009 • Theravance to Present at the 18th Annual Credit Suisse Health Care Conference Marketwire (Tue, Nov 3) Mon, Nov 2, 2009 • Theravance Announces New Employment Inducement Award Marketwire (Mon, Nov 2) Wed, Oct 28, 2009 • Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections in Europe Marketwire (Wed, Oct 28) • THRX's Loss Wider Than Expected Zacks.com (Wed, Oct 28) Tue, Oct 27, 2009 • Theravance, Inc. Q3 2009 Earnings Call Transcript at Seeking Alpha (Tue, Oct 27) • Theravance Third Quarter 2009 Financial Results Call scheduled for 5:00 pm ET today Shareholder.com (Tue, Oct 27) • THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online (Tue, Oct 27) • Theravance Reports Third Quarter 2009 Financial Results Marketwire (Tue, Oct 27) • GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD Marketwire (Tue, Oct 27) • Q3 2009 Theravance Inc. Earnings Release - After Market Close CCBN (Tue, Oct 27) Mon, Oct 26, 2009 • Theravance Earns Milestone Payment Zacks.com (Mon, Oct 26) Thu, Oct 22, 2009 • Theravance earns $20M milestone at bizjournals.com (Thu, Oct 22) • Theravance Earns $20 Million Milestone Under Telavancin Collaboration Agreement Marketwire (Thu, Oct 22) Tue, Oct 20, 2009 • Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst Wall Street Transcript (Tue, Oct 20) Mon, Oct 19, 2009 • Theravance to Report Third Quarter 2009 Financial Results on October 27, 2009 Marketwire (Mon, Oct 19) Older Headlines - Download Recent Headlines View headlines from: Mon, Oct 19, 2009Mon, Oct 12, 2009Mon, Oct 5, 2009Mon, Sep 28, 2009Mon, Sep 21, 2009Mon, Sep 14, 2009Mon, Sep 7, 2009Mon, Aug 31, 2009Mon, Aug 24, 2009Mon, Aug 17, 2009 Add THRX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage